Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans (Q39603076)

13 September 2017

title

Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans (English)

1 reference

13 September 2017

1 reference

1 reference

Antonella Torosantucci

object named as

Antonella Torosantucci

11

0 references

Ten Feizi

object named as

Ten Feizi

8

0 references

Antonio Cassone

9

object named as

Antonio Cassone

1 reference

13 September 2017

Cristina Capodicasa

1

1 reference

13 September 2017

Paola Chiani

2

1 reference

13 September 2017

Carla Bromuro

3

1 reference

13 September 2017

Flavia De Bernardis

4

1 reference

13 September 2017

Marcello Catellani

5

1 reference

13 September 2017

Angelina S Palma

6

1 reference

13 September 2017

Yan Liu

7

1 reference

13 September 2017

Eugenio Benvenuto

10

1 reference

13 September 2017

publication date

25 January 2011

1 reference

Plant Biotechnology Journal

13 September 2017

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

776-787

1 reference

Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Passive antibody therapy for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Fungal vaccines: real progress from real challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Antibody humanization: a case of the 'Emperor's new clothes'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Production of antibodies in plants: status after twenty years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Identification of peptidases in Nicotiana tabacum leaf intercellular fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Invasive fungal infections: a review of epidemiology and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

History and update on host defense against vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Plant-specific glycosylation patterns in the context of therapeutic protein production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Candida albicans cell wall comprises a branched beta-D-(1-->6)-glucan with beta-D-(1-->3)-side chains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Glycosylation as a strategy to improve antibody-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Function and glycosylation of plant-derived antiviral monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Inhibition of tumor growth by plant-derived mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Recombinant antibodies: a natural partner in combinatorial antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

An insight into the antifungal pipeline: selected new molecules and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Cost-effective production of a vaginal protein microbicide to prevent HIV transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

How the host fights against Candida infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Management of patients with recurrent vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Plants as bioreactors for the production of vaccine antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

The immunoglobulin constant region contributes to affinity and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Molecular farming in plants: host systems and expression technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Retracted: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

Optimization of Agrobacterium-mediated transient assays of gene expression in lettuce, tomato and Arabidopsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-7652.2010.00586.X

10.1111/J.1467-7652.2010.00586.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference